{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["PANoptosis", "apigenin", "cholestatic liver fibrosis", "inflammation", "transcriptotype-based drug screening", "type-I IFN"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38539789", "DateRevised": {"Year": "2024", "Month": "03", "Day": "30"}, "Article": {"Language": ["eng"], "ELocationID": ["256", "10.3390/antiox13030256"], "ArticleDate": [{"Year": "2024", "Month": "02", "Day": "20"}], "Journal": {"ISSN": "2076-3921", "JournalIssue": {"Volume": "13", "Issue": "3", "PubDate": {"Year": "2024", "Month": "Feb", "Day": "20"}}, "Title": "Antioxidants (Basel, Switzerland)", "ISOAbbreviation": "Antioxidants (Basel)"}, "ArticleTitle": "Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses.", "Abstract": {"AbstractText": ["Cholangiopathies lack effective medicines and can progress into end-stage liver diseases. Mining natural product transcriptome databases for bioactive ingredients, which can reverse disease-associated transcriptomic phenotypes, holds promise as an effective approach for drug discovery. To identify disease-associated transcriptomic changes, we performed RNA-sequencing on bile duct ligation (BDL)-induced cholestatic liver fibrosis mice, as well as PBC and PSC patients, and found that PANoptosis and activation of type-I interferon (IFN) signaling were observed in BDL mice and patients with PBC and PSC. We then established a transcriptotype-driven screening system based on HERB and ITCM databases. Among 283 natural ingredients screened, apigenin (Api), which is widely distributed in varieties of food and medicinal plants, was screened out by our screen system since it reversed the expression pattern of key genes associated with PANoptosis and type-I IFN responses. In BDL, <i>Abcb4</i><sup>-/-</sup>, and DDC-fed mice, Api effectively ameliorated liver injuries, inflammation, and fibrosis. It also protected cholangiocytes from bile acid-stimulated PANoptosis, thus alleviating damage-associated molecular pattern-mediated activation of TBK1-NF-\u03baB in macrophages. Additionally, Api directly inhibited type-I IFN-induced downstream inflammatory responses. Our study demonstrated the pathogenic roles of PANoptosis and type-I IFN signaling in cholestatic liver fibrosis and verified the feasibility of transcriptotype-based drug screening. Furthermore, this study revealed a novel anti-inflammatory mechanism of Api and identified it as a promising candidate for the treatment of cholestatic liver fibrosis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Beijing University of Chinese Medicine, 11 Bei San Huan Dong Road, Beijing 100029, China."}], "LastName": "Duan", "ForeName": "Shuni", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Beijing University of Chinese Medicine, 11 Bei San Huan Dong Road, Beijing 100029, China."}], "LastName": "Li", "ForeName": "Xin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nephrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100007, China."}], "LastName": "Han", "ForeName": "Junsong", "Initials": "J"}, {"Identifier": ["0009-0004-4100-032X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Beijing University of Chinese Medicine, 11 Bei San Huan Dong Road, Beijing 100029, China."}], "LastName": "Yang", "ForeName": "Yang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China."}], "LastName": "Luo", "ForeName": "Ranyi", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Beijing University of Chinese Medicine, 11 Bei San Huan Dong Road, Beijing 100029, China."}], "LastName": "Cai", "ForeName": "Yajie", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China."}], "LastName": "Li", "ForeName": "Xiaojiaoyang", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Beijing University of Chinese Medicine, 11 Bei San Huan Dong Road, Beijing 100029, China."}], "LastName": "Zheng", "ForeName": "Qi", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China."}], "LastName": "Guo", "ForeName": "Jincheng", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Beijing University of Chinese Medicine, 11 Bei San Huan Dong Road, Beijing 100029, China."}], "LastName": "Liu", "ForeName": "Runping", "Initials": "R"}], "GrantList": [{"GrantID": "82322075", "Agency": "Excellent Young Scientist Fund, National Natural Science Foundation of China", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Antioxidants (Basel)", "NlmUniqueID": "101668981", "ISSNLinking": "2076-3921"}, "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Wang Y., Aoki H., Yang J., Peng K., Liu R., Li X., Qiang X., Sun L., Gurley E.C., Lai G., et al. The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice. Hepatology. 2017;65:2005\u20132018. doi: 10.1002/hep.29076.", "ArticleIdList": ["10.1002/hep.29076", "PMC5444993", "28120434"]}, {"Citation": "Song Y., Tran M., Wang L., Shin D.J., Wu J. MiR-200c-3p targets SESN1 and represses the IL-6/AKT loop to prevent cholangiocyte activation and cholestatic liver fibrosis. Lab. Investig. 2022;102:485\u2013493. doi: 10.1038/s41374-021-00710-6.", "ArticleIdList": ["10.1038/s41374-021-00710-6", "PMC9042705", "34880414"]}, {"Citation": "O\u2019Hara S.P., Tabibian J.H., Splinter P.L., LaRusso N.F. The dynamic biliary epithelia: Molecules, pathways, and disease. J. Hepatol. 2013;58:575\u2013582. doi: 10.1016/j.jhep.2012.10.011.", "ArticleIdList": ["10.1016/j.jhep.2012.10.011", "PMC3831345", "23085249"]}, {"Citation": "Gudipaty S.A., Conner C.M., Rosenblatt J., Montell D.J. Unconventional Ways to Live and Die: Cell Death and Survival in Development, Homeostasis, and Disease. Annu. Rev. Cell Dev. Biol. 2018;34:311\u2013332. doi: 10.1146/annurev-cellbio-100616-060748.", "ArticleIdList": ["10.1146/annurev-cellbio-100616-060748", "PMC6791364", "30089222"]}, {"Citation": "Hu L., Chen M., Chen X., Zhao C., Fang Z., Wang H., Dai H. Chemotherapy-induced pyroptosis is mediated by BAK/BAX-caspase-3-GSDME pathway and inhibited by 2-bromopalmitate. Cell Death Dis. 2020;11:281. doi: 10.1038/s41419-020-2476-2.", "ArticleIdList": ["10.1038/s41419-020-2476-2", "PMC7181755", "32332857"]}, {"Citation": "Orning P., Weng D., Starheim K., Ratner D., Best Z., Lee B., Brooks A., Xia S., Wu H., Kelliher M.A., et al. Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death. Science. 2018;362:1064\u20131069. doi: 10.1126/science.aau2818.", "ArticleIdList": ["10.1126/science.aau2818", "PMC6522129", "30361383"]}, {"Citation": "Shlomovitz I., Erlich Z., Arad G., Edry-Botzer L., Zargarian S., Cohen H., Manko T., Ofir-Birin Y., Cooks T., Regev-Rudzki N., et al. Proteomic analysis of necroptotic extracellular vesicles. Cell Death Dis. 2021;12:1059. doi: 10.1038/s41419-021-04317-z.", "ArticleIdList": ["10.1038/s41419-021-04317-z", "PMC8575773", "34750357"]}, {"Citation": "Malireddi R.K.S., Kesavardhana S., Kanneganti T.D. ZBP1 and TAK1: Master Regulators of NLRP3 Inflammasome/Pyroptosis, Apoptosis, and Necroptosis (PAN-optosis) Front. Cell. Infect. Microbiol. 2019;9:406. doi: 10.3389/fcimb.2019.00406.", "ArticleIdList": ["10.3389/fcimb.2019.00406", "PMC6902032", "31850239"]}, {"Citation": "Karki R., Sundaram B., Sharma B.R., Lee S., Malireddi R.K.S., Nguyen L.N., Christgen S., Zheng M., Wang Y., Samir P., et al. ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis. Cell Rep. 2021;37:109858. doi: 10.1016/j.celrep.2021.109858.", "ArticleIdList": ["10.1016/j.celrep.2021.109858", "PMC8853634", "34686350"]}, {"Citation": "Zhang H.R., Li Y.P., Shi Z.J., Liang Q.Q., Chen S.Y., You Y.P., Yuan T., Xu R., Xu L.H., Ouyang D.Y., et al. Triptolide induces PANoptosis in macrophages and causes organ injury in mice. Apoptosis. 2023;28:1646\u20131665. doi: 10.1007/s10495-023-01886-6.", "ArticleIdList": ["10.1007/s10495-023-01886-6", "37702860"]}, {"Citation": "Tong J., Lan X.T., Zhang Z., Liu Y., Sun D.Y., Wang X.J., Ou-Yang S.X., Zhuang C.L., Shen F.M., Wang P., et al. Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: Potential involvement of PANoptosis. Acta Pharmacol. Sin. 2023;44:1014\u20131028. doi: 10.1038/s41401-022-01010-5.", "ArticleIdList": ["10.1038/s41401-022-01010-5", "PMC10104837", "36323829"]}, {"Citation": "Du S., Chen G., Yuan B., Hu Y., Yang P., Chen Y., Zhao Q., Zhou J., Fan J., Zeng Z. DNA sensing and associated type 1 interferon signaling contributes to progression of radiation-induced liver injury. Cell. Mol. Immunol. 2021;18:1718\u20131728. doi: 10.1038/s41423-020-0395-x.", "ArticleIdList": ["10.1038/s41423-020-0395-x", "PMC8245603", "32203191"]}, {"Citation": "Luo X., Li H., Ma L., Zhou J., Guo X., Woo S.L., Pei Y., Knight L.R., Deveau M., Chen Y., et al. Expression of STING Is Increased in Liver Tissues From Patients with NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice. Gastroenterology. 2018;155:1971\u20131984.e4. doi: 10.1053/j.gastro.2018.09.010.", "ArticleIdList": ["10.1053/j.gastro.2018.09.010", "PMC6279491", "30213555"]}, {"Citation": "Kato Y., Park J., Takamatsu H., Konaka H., Aoki W., Aburaya S., Ueda M., Nishide M., Koyama S., Hayama Y., et al. Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus. Ann. Rheum. Dis. 2018;77:1507\u20131515. doi: 10.1136/annrheumdis-2018-212988.", "ArticleIdList": ["10.1136/annrheumdis-2018-212988", "PMC6161667", "29945921"]}, {"Citation": "Hao Y., Yang B., Yang J., Shi X., Yang X., Zhang D., Zhao D., Yan W., Chen L., Zheng H., et al. ZBP1: A Powerful Innate Immune Sensor and Double-Edged Sword in Host Immunity. Int. J. Mol. Sci. 2022;23:10224. doi: 10.3390/ijms231810224.", "ArticleIdList": ["10.3390/ijms231810224", "PMC9499459", "36142136"]}, {"Citation": "Yang D., Liang Y., Zhao S., Ding Y., Zhuang Q., Shi Q., Ai T., Wu S.Q., Han J. ZBP1 mediates interferon-induced necroptosis. Cell. Mol. Immunol. 2020;17:356\u2013368. doi: 10.1038/s41423-019-0237-x.", "ArticleIdList": ["10.1038/s41423-019-0237-x", "PMC7109092", "31076724"]}, {"Citation": "Sun Y.K., Zhang Y.F., Xie L., Rong F., Zhu X.Y., Xie J., Zhou H., Xu T. Progress in the treatment of drug-induced liver injury with natural products. Pharmacol. Res. 2022;183:106361. doi: 10.1016/j.phrs.2022.106361.", "ArticleIdList": ["10.1016/j.phrs.2022.106361", "35882295"]}, {"Citation": "Yan T., Yan N., Wang P., Xia Y., Hao H., Wang G., Gonzalez F.J. Herbal drug discovery for the treatment of nonalcoholic fatty liver disease. Acta Pharm. Sin. B. 2020;10:3\u201318. doi: 10.1016/j.apsb.2019.11.017.", "ArticleIdList": ["10.1016/j.apsb.2019.11.017", "PMC6977016", "31993304"]}, {"Citation": "Zheng S., Cao P., Yin Z., Wang X., Chen Y., Yu M., Xu B., Liao C., Duan Y., Zhang S., et al. Apigenin protects mice against 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced cholestasis. Food Funct. 2021;12:2323\u20132334. doi: 10.1039/D0FO02910F.", "ArticleIdList": ["10.1039/D0FO02910F", "33620063"]}, {"Citation": "Feng X., Weng D., Zhou F., Owen Y.D., Qin H., Zhao J., Huang Y., Chen J., Fu H., Yang N., et al. Activation of PPAR\u03b3 by a Natural Flavonoid Modulator, Apigenin Ameliorates Obesity-Related Inflammation Via Regulation of Macrophage Polarization. EBioMedicine. 2016;9:61\u201376. doi: 10.1016/j.ebiom.2016.06.017.", "ArticleIdList": ["10.1016/j.ebiom.2016.06.017", "PMC4972579", "27374313"]}, {"Citation": "Ma Z., Xue X., Bai J., Cai Y., Jin X., Jia K., Ding M., Lyu X., Li X. Si-Wu-Tang ameliorates bile duct ligation-induced liver fibrosis via modulating immune environment. Biomed. Pharmacother. 2022;155:113834. doi: 10.1016/j.biopha.2022.113834.", "ArticleIdList": ["10.1016/j.biopha.2022.113834", "36271584"]}, {"Citation": "Lin J.F., Hu P.S., Wang Y.Y., Tan Y.T., Yu K., Liao K., Wu Q.N., Li T., Meng Q., Lin J.Z., et al. Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis. Signal Transduct. Target. Ther. 2022;7:54. doi: 10.1038/s41392-022-00889-0.", "ArticleIdList": ["10.1038/s41392-022-00889-0", "PMC8882671", "35221331"]}, {"Citation": "Xiang B., Deng C., Qiu F., Li J., Li S., Zhang H., Lin X., Huang Y., Zhou Y., Su J., et al. Single cell sequencing analysis identifies genetics-modulated ORMDL3(+) cholangiocytes having higher metabolic effects on primary biliary cholangitis. J. Nanobiotechnol. 2021;19:406. doi: 10.1186/s12951-021-01154-2.", "ArticleIdList": ["10.1186/s12951-021-01154-2", "PMC8647381", "34872583"]}, {"Citation": "Wan Y., Meng F., Wu N., Zhou T., Venter J., Francis H., Kennedy L., Glaser T., Bernuzzi F., Invernizzi P., et al. Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells. Hepatology. 2017;66:528\u2013541. doi: 10.1002/hep.29138.", "ArticleIdList": ["10.1002/hep.29138", "PMC5519428", "28256736"]}, {"Citation": "Hao H., Cao L., Jiang C., Che Y., Zhang S., Takahashi S., Wang G., Gonzalez F.J. Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis. Cell Metab. 2017;25:856\u2013867.e5. doi: 10.1016/j.cmet.2017.03.007.", "ArticleIdList": ["10.1016/j.cmet.2017.03.007", "PMC6624427", "28380377"]}, {"Citation": "Guicciardi M.E., Trussoni C.E., Krishnan A., Bronk S.F., Lorenzo Pisarello M.J., O\u2019Hara S.P., Splinter P.L., Gao Y., Vig P., Revzin A., et al. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice. J. Hepatol. 2018;69:676\u2013686. doi: 10.1016/j.jhep.2018.05.018.", "ArticleIdList": ["10.1016/j.jhep.2018.05.018", "PMC6098983", "29802947"]}, {"Citation": "Katsumi T., Guicciardi M.E., Azad A., Bronk S.F., Krishnan A., Gores G.J. Activated cholangiocytes release macrophage-polarizing extracellular vesicles bearing the DAMP S100A11. Am. J. Physiol.-Cell Physiol. 2019;317:C788\u2013C799. doi: 10.1152/ajpcell.00250.2019.", "ArticleIdList": ["10.1152/ajpcell.00250.2019", "PMC6851002", "31365294"]}, {"Citation": "Chen L., Zhao Y., Lai D., Zhang P., Yang Y., Li Y., Fei K., Jiang G., Fan J. Neutrophil extracellular traps promote macrophage pyroptosis in sepsis. Cell Death Dis. 2018;9:597. doi: 10.1038/s41419-018-0538-5.", "ArticleIdList": ["10.1038/s41419-018-0538-5", "PMC5964241", "29789550"]}, {"Citation": "Buchrieser J., Oliva-Martin M.J., Moore M.D., Long J.C.D., Cowley S.A., Perez-Sim\u00f3n J.A., James W., Venero J.L. RIPK1 is a critical modulator of both tonic and TLR-responsive inflammatory and cell death pathways in human macrophage differentiation. Cell Death Dis. 2018;9:973. doi: 10.1038/s41419-018-1053-4.", "ArticleIdList": ["10.1038/s41419-018-1053-4", "PMC6155173", "30250197"]}, {"Citation": "Duewell P., Steger A., Lohr H., Bourhis H., Hoelz H., Kirchleitner S.V., Stieg M.R., Grassmann S., Kobold S., Siveke J.T., et al. RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells. Cell Death Differ. 2014;21:1825\u20131837. doi: 10.1038/cdd.2014.96.", "ArticleIdList": ["10.1038/cdd.2014.96", "PMC4227156", "25012502"]}, {"Citation": "Wu K.K.L., Long K., Lin H., Siu P.M.F., Hoo R.L.C., Ye D., Xu A., Cheng K.K.Y. The APPL1-Rab5 axis restricts NLRP3 inflammasome activation through early endosomal-dependent mitophagy in macrophages. Nat. Commun. 2021;12:6637. doi: 10.1038/s41467-021-26987-1.", "ArticleIdList": ["10.1038/s41467-021-26987-1", "PMC8599493", "34789781"]}, {"Citation": "Guillot A., Guerri L., Feng D., Kim S.J., Ahmed Y.A., Paloczi J., He Y., Schuebel K., Dai S., Liu F., et al. Bile acid-activated macrophages promote biliary epithelial cell proliferation through integrin \u03b1v\u03b26 upregulation following liver injury. J. Clin. Investig. 2021;131:e132305. doi: 10.1172/JCI132305.", "ArticleIdList": ["10.1172/JCI132305", "PMC8087210", "33724957"]}, {"Citation": "Kuriakose T., Man S.M., Malireddi R.K., Karki R., Kesavardhana S., Place D.E., Neale G., Vogel P., Kanneganti T.D. ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci. Immunol. 2016;1:aag2045. doi: 10.1126/sciimmunol.aag2045.", "ArticleIdList": ["10.1126/sciimmunol.aag2045", "PMC5131924", "27917412"]}, {"Citation": "Karki R., Lee S., Mall R., Pandian N., Wang Y., Sharma B.R., Malireddi R.S., Yang D., Trifkovic S., Steele J.A., et al. ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection. Sci. Immunol. 2022;7:eabo6294. doi: 10.1126/sciimmunol.abo6294.", "ArticleIdList": ["10.1126/sciimmunol.abo6294", "PMC9161373", "35587515"]}, {"Citation": "Ivashkiv L.B., Donlin L.T. Regulation of type I interferon responses. Nat. Rev. Immunol. 2014;14:36\u201349. doi: 10.1038/nri3581.", "ArticleIdList": ["10.1038/nri3581", "PMC4084561", "24362405"]}, {"Citation": "Gonz\u00e1lez-Navajas J.M., Lee J., David M., Raz E. Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 2012;12:125\u2013135. doi: 10.1038/nri3133.", "ArticleIdList": ["10.1038/nri3133", "PMC3727154", "22222875"]}, {"Citation": "Bhattacharya A., Hegazy A.N., Deigendesch N., Kosack L., Cupovic J., Kandasamy R.K., Hildebrandt A., Merkler D., K\u00fchl A.A., Vilagos B., et al. Superoxide Dismutase 1 Protects Hepatocytes from Type I Interferon-Driven Oxidative Damage. Immunity. 2015;43:974\u2013986. doi: 10.1016/j.immuni.2015.10.013.", "ArticleIdList": ["10.1016/j.immuni.2015.10.013", "PMC4658338", "26588782"]}, {"Citation": "Araujo A.M., Antunes M.M., Mattos M.S., Diniz A.B., Alvarenga D.M., Nakagaki B.N., Carvalho \u00c9.D., Lacerda V.A., Carvalho-Gontijo R., Goulart J., et al. Liver Immune Cells Release Type 1 Interferon Due to DNA Sensing and Amplify Liver Injury from Acetaminophen Overdose. Cells. 2018;7:88. doi: 10.3390/cells7080088.", "ArticleIdList": ["10.3390/cells7080088", "PMC6115735", "30060463"]}, {"Citation": "Petrasek J., Dolganiuc A., Csak T., Kurt-Jones E.A., Szabo G. Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice. Gastroenterology. 2011;140:697\u2013708.e694. doi: 10.1053/j.gastro.2010.08.020.", "ArticleIdList": ["10.1053/j.gastro.2010.08.020", "PMC3031737", "20727895"]}, {"Citation": "Petrasek J., Dolganiuc A., Csak T., Nath B., Hritz I., Kodys K., Catalano D., Kurt-Jones E., Mandrekar P., Szabo G. Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells. Hepatology. 2011;53:649\u2013660. doi: 10.1002/hep.24059.", "ArticleIdList": ["10.1002/hep.24059", "PMC3069538", "21274885"]}]}], "History": [{"Year": "2023", "Month": "11", "Day": "10"}, {"Year": "2023", "Month": "12", "Day": "4"}, {"Year": "2023", "Month": "12", "Day": "12"}, {"Year": "2024", "Month": "3", "Day": "28", "Hour": "6", "Minute": "46"}, {"Year": "2024", "Month": "3", "Day": "28", "Hour": "6", "Minute": "45"}, {"Year": "2024", "Month": "3", "Day": "28", "Hour": "1", "Minute": "4"}, {"Year": "2024", "Month": "2", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["38539789", "PMC10967634", "10.3390/antiox13030256", "antiox13030256"]}}]}